Recap: Adaptive Biotechnologies Q3 Earnings
Portfolio Pulse from Benzinga Insights
Adaptive Biotechnologies (NASDAQ:ADPT) reported Q3 earnings, missing estimates by 2.94% with an EPS of $-0.35 versus an estimate of $-0.34. Revenue was down $9.91 million from the same period last year. Last quarter, the company also missed on EPS which was followed by a 12.44% drop in the share price the next day.
November 09, 2023 | 9:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Adaptive Biotechnologies missed Q3 earnings estimates and reported a YoY revenue decrease. Previous earnings miss led to a significant share price drop.
Adaptive Biotechnologies missed earnings estimates and reported a decrease in revenue compared to the same period last year. This negative financial performance could lead to a decrease in the company's share price, as was the case in the previous quarter when the company also missed earnings estimates.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100